IBRX Stock Analysis: Buy, Sell, or Hold?
IBRX - ImmunityBio, Inc. Common Stock
$8.71
0.92 (11.81%)
▲
5d:
+18.34%
30d:
+10.39%
90d:
+18.02%
HOLD
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 9.0/10
Get Alerted When IBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: IBRX is 10.7% above its trading range ($7.87). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: IBRX is 10.7% above its trading range ($7.87). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: IBRX is currently trading at $8.71, which is considered extended relative to its 30-day fair value range of $7.02 to $7.87. The stock's valuation (Forward PE: 145.2) is in line with its historical norms (132.7). At these levels, the market is pricing in 3.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, IBRX is in a downtrend. The price is approaching resistance at $8.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.8% recently.
Market Sentiment: IBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+49.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IBRX is in a downtrend. The price is approaching resistance at $8.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.8% recently.
Market Sentiment: IBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+49.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.02 -
$7.87
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding IBRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.8%)
- BULLISH: Trading 49.3% below Wall St target ($13.00)
- NEUTRAL: Market pricing in 3.0% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$7.02 -
$7.87
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.69
Resistance Level
$8.79
Current Trend
Downtrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
145.17
Wall Street Target
$13.00
(+49.3%)
Revenue Growth (YoY)
167.6%
Valuation Premium vs History
+3.0% premium
PE vs Historical
145.2 vs 132.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.0%
(market-implied from PE analysis)
1-Year Target
$8.97
(+3%)
2-Year Target
$9.24
(+6%)
3-Year Target
$9.52
(+9%)
3-Yr Target (if PE normalizes)
(PE: 145→133)
PE COMPRESSION
$8.70
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 27, 2026 5:13 AM ET
Data refreshes hourly during market hours. Next update: 6:13 AM
Data refreshes hourly during market hours. Next update: 6:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Barry J Simon
SELL
75000 shares
2026-02-24
Barry J Simon
SELL
165000 shares
2026-02-23
Christobel Selecky
SELL
25000 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 51 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 56 HOLD |
|
CNTA
Centessa Pharmaceuticals… |
STRONG BUY
11 analysts |
$44 | 61 BUY |
Advanced IBRX Option Strategies
Professional options setups generated by AI based on today's IBRX price and gamma walls.
